Short Interest in Lexaria Bioscience Corp. (NASDAQ:LEXXW) Drops By 21.0%

Lexaria Bioscience Corp. (NASDAQ:LEXXW) was the target of a significant drop in short interest during the month of January. As of January 15th, there was short interest totalling 6,400 shares, a drop of 21.0% from the December 31st total of 8,100 shares. Based on an average daily volume of 5,500 shares, the short-interest ratio is presently 1.2 days.

Lexaria Bioscience Stock Performance

LEXXW opened at $0.44 on Thursday. The business has a fifty day moving average of $0.69 and a 200 day moving average of $0.90. Lexaria Bioscience has a 52-week low of $0.43 and a 52-week high of $2.50.

Lexaria Bioscience Company Profile

Lexaria Bioscience Corp. operates as a biotechnology company. It develops and out-licenses its patented drug delivery technology, DehydraTECH, which combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods.